fluorescein-5-isothiocyanate has been researched along with Neoplasms in 96 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (4.17) | 18.7374 |
1990's | 5 (5.21) | 18.2507 |
2000's | 28 (29.17) | 29.6817 |
2010's | 52 (54.17) | 24.3611 |
2020's | 7 (7.29) | 2.80 |
Authors | Studies |
---|---|
Chen, H; Wang, Z; Zhang, H | 1 |
Chen, Y; Hu, Q; Wang, S; Zhou, L | 1 |
Babaei, E; Hesari, FS; Kandjani, BZ | 1 |
Abraham, W; Aung, A; Backlund, CM; Chen, LE; Hostetler, A; Irvine, DJ; Li, N; Maiorino, L; Melo, M; Mukkamala, V; Padilla, LT; Wolff, AN; Wu, S; Zhang, AQ | 1 |
Baybutt, TR; Bloch, E; Feigman, MS; Ferraro, NJ; Pires, MM; Sikorski, EL; Snook, AE; Thévenin, D; Wehr, J | 1 |
Chen, X; Ding, X; Gao, X; Hu, J; Li, M; Li, Q; Li, W; Li, X; Lin, B; Liu, C; Qi, W; Wang, X; Wang, Y; Wu, H; Xu, H; Xue, J; Yang, P; Yao, Z | 1 |
Amer, H; Dahlawi, H; Fahmy, CA; Gamal-Eldeen, AM; Raafat, BM; Salman, A | 1 |
Che, J; Di Carlo, D; Hur, SC | 1 |
Bibens-Laulan, N; St-Pierre, Y | 1 |
Li, K; Li, X; Lin, J; Liu, Q; Lv, G; Peng, Y; Qiu, L; Wang, S; Zhao, X | 1 |
Dai, C; Deng, G; Kang, Y; Liu, X; Wang, Q; Wang, Y; Wu, Z; Zhao, J; Zhou, F | 1 |
Gregersen, H; Luo, L; Maruf, A; Nurhidayah, D; Wang, GX; Wang, Y; Wu, W; Zhong, Y | 1 |
Chu, H; Felten, AE; Leamon, CP; Lu, YJ; Nelson, M; Parker, N; Reddy, JA; Shillingford, JM; Vaughn, JF; Vlahov, IR; Wang, EZ; Westrick, E; Xu, LC | 1 |
Obydenny, SI; Posypanova, GA; Severin, ES; Vorontsov, EA; Yabbarov, NG | 1 |
Fukumura, D; Jain, RK; Munn, LL | 1 |
Chen, H; Huo, X; Li, T; Liu, J; Wang, B; Wang, R; Yang, Z; Zhang, H; Zhang, W | 1 |
Bi, M; Cai, Q; Meng, W; Ni, Y; Wang, B; Wang, J | 1 |
Chung, M; Jeon, NL; Kim, JH; Kim, S; Lee, H | 1 |
Cheng, R; Deng, C; Meng, F; Sun, H; Zhong, Z | 1 |
Adams, DL; Alpaugh, RK; Bergan, RC; Catalona, W; Charpentier, M; Chumsri, S; Cristofanilli, M; Martin, SS; Ogden, IM; Tang, CM; Tsai, S | 1 |
Cai, L; Fang, S; Gao, D; Gao, G; Gong, P; Sheng, Z; Yang, Y; Yi, H; Zhang, P | 1 |
Cai, K; Ding, X; Hu, Y; Li, J; Liu, J; Liu, Y; Luo, Z; Zhang, B; Zhou, J | 1 |
Huang, Y; Li, L; Xu, X; Yang, Y; Zhou, Z | 1 |
Agostiano, A; Corricelli, M; Curri, ML; Denora, N; Depalo, N; Di Carlo, E; Fanizza, E; Laquintana, V; Striccoli, M | 1 |
Ding, C; Tian, Y | 1 |
Bos, C; Escoffre, JM; Moonen, C; Sasaki, N; Storm, G | 1 |
Lan, M; Tao, L; Yuan, H; Zhang, D; Zhao, H | 1 |
Ge, J; Guo, L; Jia, Q; Lan, M; Liu, Q; Liu, W; Meng, X; Wang, P; Zhang, H | 1 |
Sun, X; Zhang, J | 1 |
Chen, F; Liu, W; Peng, Y; Tang, H; Wang, B; Wang, Z; Zhang, H; Zuo, W | 1 |
Dong, R; Duffy, P; Gao, Y; Wang, D; Wang, W; Wei, X; Zhao, T; Zhu, X | 1 |
Gao, H; He, Q; Liu, Y; Mei, L; Yu, Q; Zhang, Q; Zhang, Z | 1 |
Chen, H; Chen, P; Cui, Y; Wang, Z; Wu, L; Zhang, Y; Zhu, D; Zong, S | 1 |
Cao, W; Gao, G; Gu, Y; Li, S; Liu, M; Shan, L; Wu, C; Xu, L; Zhao, L | 1 |
Koch, M; Ntziachristos, V | 1 |
Chen, HY; Liu, Z; Shen, X; Wang, S; Wang, W; Yin, D; Zhu, JJ | 1 |
Lee, RJ; Teng, L; Teng, M; Xie, J; Yang, S; Yu, B; Zhang, X | 1 |
David, A; Feinshtein, V; Golan, M | 1 |
Appold, L; Dasgupta, A; Fokong, S; Iranzo, O; Kiessling, F; Koczera, P; Kuehne, AJC; Lammers, T; Liu, M; Ojha, T; Pathak, V; Pich, A; Shi, Y; van Zandvoort, M; Wu, Z | 1 |
Bae, YH; Gao, Z; Kim, D; Kwon, IC; Lee, ES; Park, K | 1 |
Cheng, Y; Wang, X; Wen, LP; Xu, T; Yang, W | 1 |
Allan, AL; Goodale, D; Keeney, M; Phay, C; Postenka, CO | 1 |
Dynan, WS; Hu, TC; Li, S; Nguyen, L; Serkiz, SM; She, JX; Wang, M; Wicks, GG; Xiong, H | 1 |
Chen, K; Chen, X; Cheng, Z; Gao, J; Lee, S; Peng, X; Xie, J; Xie, R | 1 |
Baker, JR; Kotlyar, A; Kukowska-Latallo, J; Shukla, R; Thomas, TP | 1 |
Cheng, Z; Thorek, DL; Tsourkas, A | 1 |
Baker, JR | 1 |
Hori, K; Nishihara, M; Shiraishi, K; Yokoyama, M | 1 |
Adler, V; Bowne, WB; Michl, J; Pincus, MR; Sarafraz-Yazdi, E; Sookraj, KA | 1 |
Huang, Y; Shi, M; Ye, F; Zhao, S | 1 |
Chang, C; Chen, JX; Li, C; Quan, CY; Wang, HY; Zhang, XZ; Zhuo, RX | 1 |
Fan, M; Murdoch, WJ; Radosz, M; Shen, Y; Sui, M; Tang, J; Van Kirk, EA; Xu, P; Zhou, Z | 1 |
Balvay, D; Clement, O; Cuenod, C; Faye, N; Fournier, L; Siauve, N; Taillieu, F | 1 |
Babilas, P; Landthaler, M; Meier, RJ; Schreml, S; Szeimies, RM; Wolfbeis, OS | 1 |
Cao, X; Guo, R; Shen, M; Shi, X; Wang, Y | 1 |
Chen, S; He, L; Jiang, L; Li, N; Li, P; Shi, Y; Tan, Z; Wang, R; Zhu, X | 1 |
Andò, S; Brunelli, E; Casula, MF; Maris, P; Morelli, C; Nagy, JB; Panno, ML; Pasqua, L; Perrotta, E; Perrotta, I; Sisci, D; Tagarelli, A; Testa, F; Versace, C | 1 |
Ma, DX; Qi, XR; Shi, NQ | 1 |
Huang, Y; Liu, YM; Shi, M; Ye, F; Zhao, S | 1 |
Haimovitz-Friedman, A; Thin, TH; Verheij, M; Yang, TJ | 1 |
Al Numair, KS; Alsaif, MA; Baskar, AA; Ignacimuthu, S | 1 |
Acharya, B; Baek, MC; Bonaparte, N; Chi, L; He, X; Kim, IS; Kim, JH; Kim, S; Lee, BH; Lee, EK; Lee, HJ; Lee, JY; Moon, PG; Paik, YK | 1 |
Endoh, Y; Iwadate, M; Kanazawa, M; Mori, Y; Ohki, S; Sekikawa, K; Suzuki, S; Takenoshita, S; Takita, K; Yoshihara, K | 1 |
Boucher, Y; Brown, EB; Jain, RK; Nasser, S | 1 |
Mechetner, E; Samoszuk, MK; Walter, J | 1 |
Brunner, M; Gehrmann, M; Kremmer, E; Multhoff, G; Pfister, K; Reichle, A | 1 |
Baffert, F; Baluk, P; Hashizume, H; Haskell, A; Hu-Lowe, DD; Inai, T; Mancuso, M; McDonald, DM; Shalinsky, DR; Thurston, G; Yancopoulos, GD | 1 |
Fu, A; Geng, L; Hallahan, D; Konjeti, S; Osusky, K | 1 |
Date, I; Ichikawa, T; Lu, YF; Matsui, H; Matsushita, M; Michiue, H; Tamiya, T; Tomizawa, K; Wei, FY | 1 |
Altmann, A; Askoxylakis, V; Eisenhut, M; Haberkorn, U; Kinscherf, R; Krämer, S; Mier, W; Schad, A; Zitzmann, S | 1 |
Baker, JR; Choi, Y | 1 |
Ansaldo, G; Basso, M; Borgonovo, G; Ceppa, P; Fenoglio, D; Ferrera, F; Filaci, G; Fiocca, R; Fravega, M; Indiveri, F; Murdaca, G; Picciotto, A; Rizzi, M; Setti, M; Torre, G | 1 |
Batich, CD; Chatel, D; Dutta, D; Liesenfeld, B; Mericle, RA; Moudgil, BM; Santra, S; Tan, W | 1 |
Akira, S; Bhattacharjee, RN; Honda, T; Iida, T; Kumagai, Y; Okada, K; Park, KS; Takeuchi, O; Uematsu, S | 1 |
Bazak, Z; Elias, O; Fingerut, E; Frankenburg, S; Levy, A; Peretz, T; Pitcovski, J; Wasserman, E | 1 |
Hayashi, Y; Kiso, Y; Lloyd, GK; Miller, BR; Neuteboom, ST; Nicholson, B; Palladino, MA | 1 |
Berg, K; Bonsted, A; Bown, SG; Selbo, PK; Weyergang, A | 1 |
Ntziachristos, V; Ripoll, J; Shih, H; Weissleder, R; Zacharakis, G | 1 |
Han, W; Jiang, C; Li, M; Liu, Y; Qin, X; Ran, Y; Wan, Y; Wang, W; Wu, S; Xue, X; You, Y; Zhang, C; Zhang, Y; Zhang, Z; Zhu, W | 1 |
Deguchi, A; Kuriyama, S; Masaki, T; Nakai, S; Nonomura, T; Ogawa, M; Uchida, N; Yoshiji, H | 1 |
Chen, C; Huang, J; Jiang, Y; Jiang, Z; Liu, G; Sun, Y; Xu, J; Zhao, Y | 1 |
Makale, M | 1 |
Imai, S; Kamada, H; Mukai, Y; Nagano, K; Nakagawa, S; Shibata, H; Sugita, T; Tsunoda, S; Tsutsumi, Y; Yamanada, N; Yoshida, Y; Yoshikawa, T; Yoshioka, Y | 1 |
Hiraoka, M; Kimura, S; Kizaka-Kondoh, S; Makino, A; Tanaka, S; Tanisaka, H | 1 |
Li, YS; McHale, AP; Reid, CN | 1 |
Hedley, D; Musgrove, E; Rugg, C; Taylor, I | 1 |
Friedrich, A; Glass, W; Jenssen, HL; Mix, E | 1 |
Louis, CJ; Wyllie, RG | 1 |
Cremer, T; du Manoir, S; Holtgreve-Grez, H; Lengauer, C; Ried, T; Schoell, B; Schröck, E; Speicher, MR | 1 |
Abeln, EC; Bonsing, BA; Cornelisse, CJ; Corver, WE; Fleuren, GJ; Vlak-Theil, PM | 1 |
Hoffmann, J; Menrad, A; Schirner, M; Schneider, MR | 1 |
Ohyashiki, JH; Ohyashiki, K | 1 |
Chucholowski, N; Goretzki, L; Graeff, H; Jänicke, F; Kramer, M; Moniwa, N; Schmitt, M; Schüren, E; Wagner, B; Weidle, U | 1 |
Gray, JW; Kallioniemi, A; Kallioniemi, OP; Pinkel, D; Rutovitz, D; Sudar, D; Waldman, F | 1 |
Harada, S; Purtilo, DT; Sinangil, F; Volsky, DJ | 1 |
6 review(s) available for fluorescein-5-isothiocyanate and Neoplasms
Article | Year |
---|---|
Advancing Surgical Vision with Fluorescence Imaging.
Topics: Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Indocyanine Green; Lymph Nodes; Lymphatic Metastasis; Molecular Imaging; Neoplasm Staging; Neoplasms; Optical Imaging; Perfusion; Sentinel Lymph Node Biopsy | 2016 |
Dendrimer-based nanoparticles for cancer therapy.
Topics: Animals; Antineoplastic Agents; Capillary Permeability; Carrier Proteins; Contrast Media; Dendrimers; DNA; Drug Carriers; Drug Delivery Systems; Drug Design; Fluorescein-5-isothiocyanate; Folate Receptors, GPI-Anchored; Humans; KB Cells; Methotrexate; Mice; Mice, Nude; Models, Molecular; Nanoparticles; Neoplasms; Receptors, Cell Surface; Tissue Distribution; Xenograft Model Antitumor Assays | 2009 |
Imaging radiotherapy-induced apoptosis.
Topics: Animals; Annexin A5; Apoptosis; Caspase 3; Chemoradiotherapy; Clinical Trials as Topic; Contrast Media; Diffusion Magnetic Resonance Imaging; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Mice; Microbubbles; Molecular Imaging; Neoplasms; Organotechnetium Compounds; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Radiotherapy; Radiotherapy Dosage; Receptors, Death Domain; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ultrasonography | 2012 |
Intravital imaging and cell invasion.
Topics: Animals; Cell Line, Tumor; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Green Fluorescent Proteins; Humans; Integrins; Neoplasm Invasiveness; Neoplasms; Rhodamines; Staining and Labeling | 2007 |
In Situ TRAP assay detection of telomerase activity in cytological preparations.
Topics: Animals; Cells; DNA Primers; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Hypertonic Solutions; Hypotonic Solutions; Microscopy, Fluorescence; Neoplasms; Neoplastic Stem Cells; Polymerase Chain Reaction; Telomerase | 2002 |
Flow cytofluorometry in tumour cell receptor analysis. Survey of the literature and recent developments concerning the urokinase-type plasminogen activator (uPA).
Topics: Animals; Endopeptidases; Flow Cytometry; Fluorescein-5-isothiocyanate; Humans; Models, Biological; Neoplasms; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Recombinant Proteins; Urokinase-Type Plasminogen Activator | 1992 |
90 other study(ies) available for fluorescein-5-isothiocyanate and Neoplasms
Article | Year |
---|---|
A ratiometric fluorescent probe based on peptide modified MnFe
Topics: Animals; Fluorescein-5-isothiocyanate; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; Matrix Metalloproteinase 7; Mice; Nanoparticles; Neoplasms; Peptides | 2022 |
Self-emulsifying System Co-loaded with Paclitaxel and Coix Seed Oil Deeply Penetrated to Enhance Efficacy in Cervical Cancer.
Topics: Cell Line, Tumor; Coix; Fluorescein-5-isothiocyanate; HeLa Cells; Humans; Neoplasms; Paclitaxel; Plant Oils | 2023 |
Gemini curcumin inhibits 4T1 cancer cell proliferation and modulates the expression of apoptotic and metastatic genes in Balb/c mice model.
Topics: Animals; Annexin A5; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Curcumin; Fluorescein-5-isothiocyanate; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasms | 2023 |
Universal redirection of CAR T cells against solid tumours via membrane-inserted ligands for the CAR.
Topics: Animals; Fluorescein-5-isothiocyanate; Humans; Immunotherapy, Adoptive; Ligands; Mice; Neoplasms; T-Lymphocytes | 2023 |
pH-Dependent Grafting of Cancer Cells with Antigenic Epitopes Promotes Selective Antibody-Mediated Cytotoxicity.
Topics: 2,4-Dinitrophenol; Amino Acid Sequence; Animals; Antibodies, Monoclonal; Cell Line, Tumor; Epitopes; Fluorescein-5-isothiocyanate; Humans; Hydrogen-Ion Concentration; Immunologic Factors; Immunotherapy; Killer Cells, Natural; Membrane Proteins; Mice; Neoplasms | 2020 |
Enhanced Safety and Antitumor Efficacy of Switchable Dual Chimeric Antigen Receptor-Engineered T Cells against Solid Tumors through a Synthetic Bifunctional PD-L1-Blocking Peptide.
Topics: Animals; B7-H1 Antigen; Cell Line, Tumor; Cytokines; Fluorescein-5-isothiocyanate; GPI-Linked Proteins; Humans; Immunotherapy, Adoptive; Mesothelin; Mice; Mice, Nude; Neoplasms; Peptides; Receptors, Chimeric Antigen; T-Lymphocytes; Xenograft Model Antitumor Assays | 2020 |
Sulfated Extract of Abelmoschus Esculentus: A Potential Cancer Chemo-preventive Agent.
Topics: Abelmoschus; Animals; Apoptosis; Female; Fluorescein-5-isothiocyanate; Humans; Lipopolysaccharides; Neoplasms; Nitric Oxide; Placenta; Plant Extracts; Pregnancy; Rats; Sulfates | 2022 |
Microscale Laminar Vortices for High-Purity Extraction and Release of Circulating Tumor Cells.
Topics: Antibodies, Monoclonal; Biomarkers, Tumor; Cell Count; Cell Separation; Cell Size; Dimethylpolysiloxanes; Equipment Design; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique; Fluorescent Dyes; Humans; Immunoconjugates; Keratins; Lab-On-A-Chip Devices; Leukocyte Common Antigens; Microfluidic Analytical Techniques; Neoplasms; Neoplastic Cells, Circulating; Nylons; Phycoerythrin; Protein Binding; Rheology | 2017 |
Intracellular galectin-7 expression in cancer cells results from an autocrine transcriptional mechanism and endocytosis of extracellular galectin-7.
Topics: Autocrine Communication; Blotting, Western; Cell Line, Tumor; Endocytosis; Extracellular Space; Female; Fluorescein-5-isothiocyanate; Galectins; Gene Expression Regulation, Neoplastic; Humans; Intracellular Space; Microscopy, Confocal; Mitochondria; Neoplasms; Recombinant Proteins; RNA, Messenger; Transcription, Genetic | 2017 |
Enhanced Tumor Diagnostic and Therapeutic Effect of Mesoporous Silica Nanoparticle-Mediated Pre-targeted Strategy.
Topics: Aza Compounds; Biotin; Cell Survival; Cyclooctanes; Drug Carriers; Fluorescein-5-isothiocyanate; Fluorescent Dyes; HeLa Cells; Humans; Inhibitory Concentration 50; Intravital Microscopy; Membrane Potential, Mitochondrial; Microscopy, Fluorescence; Nanoparticles; Neoplasms; Porosity; Ruthenium Compounds; Silicon Dioxide | 2018 |
Exchangeability of FITC-SiO₂ Nanoparticles Between Cancer Cells Increases the Range of Drug Delivery.
Topics: Drug Delivery Systems; Fluorescein; Fluorescein-5-isothiocyanate; Nanoparticles; Neoplasms; Silicon Dioxide | 2018 |
Targeted polyethylenimine/(p53 plasmid) nanocomplexes for potential antitumor applications.
Topics: Cell Survival; Drug Carriers; Fluorescein-5-isothiocyanate; Folate Receptors, GPI-Anchored; Folic Acid; Genetic Therapy; Genetic Vectors; HeLa Cells; Hep G2 Cells; Humans; Nanoconjugates; Neoplasms; Particle Size; Plasmids; Polyethyleneimine; Tumor Suppressor Protein p53 | 2019 |
Detecting Functional and Accessible Folate Receptor Expression in Cancer and Polycystic Kidneys.
Topics: A549 Cells; Animals; Doxycycline; Fluorescein-5-isothiocyanate; Folate Receptor 1; Folic Acid; HeLa Cells; Humans; Lysine; Mice; Mice, Inbred BALB C; Mice, Nude; Mice, Transgenic; Molecular Targeted Therapy; Neoplasms; Oligopeptides; Polycystic Kidney Diseases; Protein Kinase C; Tissue Distribution; Trityl Compounds; Xenograft Model Antitumor Assays | 2019 |
A new system for targeted delivery of doxorubicin into tumor cells.
Topics: alpha-Fetoproteins; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Dendrimers; Doxorubicin; Drug Delivery Systems; Endocytosis; Fluorescein-5-isothiocyanate; Humans; Lymphocytes; Neoplasms | 2013 |
Measuring angiogenesis and hemodynamics in mice.
Topics: Administration, Intravenous; Animals; Dextrans; Disease Models, Animal; Fluorescein-5-isothiocyanate; Hemodynamics; Image Processing, Computer-Assisted; Mice; Microscopy, Fluorescence; Microscopy, Video; Neoplasms; Neovascularization, Pathologic; Neovascularization, Physiologic; Staining and Labeling | 2013 |
A multifunctional nanoprobe based on Au-Fe3O4 nanoparticles for multimodal and ultrasensitive detection of cancer cells.
Topics: Animals; Benzidines; Colorimetry; Europium; Fluorescein-5-isothiocyanate; Folic Acid; Folic Acid Transporters; Gold; HeLa Cells; Humans; Magnetic Resonance Imaging; Magnetite Nanoparticles; Mice; Neoplasms; NIH 3T3 Cells; Optical Imaging; Picolinic Acids | 2013 |
Uniform magnesium silicate hollow spheres as high drug-loading nanocarriers for cancer therapy with low systemic toxicity.
Topics: Animals; Antineoplastic Agents; Drug Carriers; Endocytosis; Female; Fluorescein-5-isothiocyanate; Hemolysis; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Lysosomes; Magnesium Silicates; Mice; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Nanoparticles; Neoplasm Transplantation; Neoplasms; Particle Size; Tetrazolium Salts; Thiazoles | 2013 |
A bioengineered array of 3D microvessels for vascular permeability assay.
Topics: Antibodies, Monoclonal, Humanized; Antigens, CD; Bevacizumab; Bioengineering; Blood Vessels; Cadherins; Capillary Permeability; Cell Communication; Cell Line, Tumor; Claudin-5; Fibroblasts; Fluorescein-5-isothiocyanate; Human Umbilical Vein Endothelial Cells; Humans; Hydrogels; Microcirculation; Microfluidic Analytical Techniques; Microfluidics; Microvessels; Neoplasms; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Zonula Occludens-1 Protein | 2014 |
Reduction and pH dual-bioresponsive crosslinked polymersomes for efficient intracellular delivery of proteins and potent induction of cancer cell apoptosis.
Topics: Acrylic Resins; Animals; Apoptosis; Cattle; Colloids; Cross-Linking Reagents; Cytochromes c; Fluorescein-5-isothiocyanate; HeLa Cells; Horses; Humans; Hydrogen-Ion Concentration; Intracellular Space; Magnetic Resonance Spectroscopy; MCF-7 Cells; Methacrylates; Nanoparticles; Neoplasms; Oxidation-Reduction; Particle Size; Polyethylene Glycols; Polymers; Serum Albumin, Bovine; Solubility; Water | 2014 |
Circulating giant macrophages as a potential biomarker of solid tumors.
Topics: Biomarkers; Biopsy; Cell Movement; Cell Size; Filtration; Fluorescein-5-isothiocyanate; Giant Cells; Humans; In Situ Hybridization, Fluorescence; Kaplan-Meier Estimate; Macrophages; Microscopy; Neoplasms; Neoplastic Cells, Circulating | 2014 |
Polypeptide micelles with dual pH activatable dyes for sensing cells and cancer imaging.
Topics: Cell Line; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Hydrogen-Ion Concentration; Lactams; Micelles; Nanoparticles; Neoplasms; Optical Imaging; Rhodamines | 2014 |
Hydrazone-bearing PMMA-functionalized magnetic nanocubes as pH-responsive drug carriers for remotely targeted cancer therapy in vitro and in vivo.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Biocompatible Materials; Doxorubicin; Drug Carriers; Endocytosis; Female; Fluorescein-5-isothiocyanate; HeLa Cells; Humans; Hydrazones; Hydrogen-Ion Concentration; Magnetic Resonance Imaging; Magnetite Nanoparticles; Mice; Mice, Nude; Neoplasms; Polymethyl Methacrylate; Transplantation, Heterologous | 2014 |
Tumor targeting by pH-sensitive, biodegradable, cross-linked N-(2-hydroxypropyl) methacrylamide copolymer micelles.
Topics: Acrylamides; Alanine Transaminase; Animals; Antineoplastic Agents; Aspartate Aminotransferases; Biocompatible Materials; Cell Line, Tumor; Cross-Linking Reagents; Doxorubicin; Endocytosis; Female; Fluorescein-5-isothiocyanate; Humans; Hydrogen-Ion Concentration; Liver; Mice; Micelles; Microscopy, Electron, Transmission; Neoplasms; Polymers; Sitosterols; Tissue Distribution; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |
Biotin-decorated silica coated PbS nanocrystals emitting in the second biological near infrared window for bioimaging.
Topics: Amines; Biotin; Fluorescein-5-isothiocyanate; Humans; Lead; Nanoparticles; Neoplasms; Particle Size; Silicon Dioxide; Spectroscopy, Near-Infrared; Streptavidin; Sulfides | 2014 |
Gold nanocluster-based fluorescence biosensor for targeted imaging in cancer cells and ratiometric determination of intracellular pH.
Topics: A549 Cells; Biosensing Techniques; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Folate Receptors, GPI-Anchored; Folic Acid; Gold; HeLa Cells; Humans; Hydrogen-Ion Concentration; Metal Nanoparticles; Neoplasms; Optical Imaging; Spectrometry, Fluorescence | 2015 |
Development of a tumor tissue-mimicking model with endothelial cell layer and collagen gel for evaluating drug penetration.
Topics: Cell Line, Tumor; Coculture Techniques; Collagen Type I; Dextrans; Fluorescein-5-isothiocyanate; Human Umbilical Vein Endothelial Cells; Humans; Microbubbles; Models, Biological; Neoplasms; Sonication | 2015 |
A functional drug delivery platform for targeting and imaging cancer cells based on Pluronic F127.
Topics: Cell Proliferation; Cells, Cultured; Drug Carriers; Drug Delivery Systems; Drug Evaluation, Preclinical; Fluorescein-5-isothiocyanate; Folic Acid; HeLa Cells; Humans; Micelles; Neoplasms; Optical Imaging; Poloxamer; Solanaceous Alkaloids | 2015 |
Red-Emissive Carbon Dots for Fluorescent, Photoacoustic, and Thermal Theranostics in Living Mice.
Topics: Animals; Carbon; Electron Spin Resonance Spectroscopy; Fluorescein-5-isothiocyanate; HeLa Cells; Humans; Lasers; Mice; Microscopy, Confocal; Neoplasms; Photoacoustic Techniques; Phototherapy; Quantum Dots; Reactive Oxygen Species; Theranostic Nanomedicine | 2015 |
STAT3 Decoy ODN Therapy for Cancer.
Topics: Animals; Apoptosis; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Enzyme Assays; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Fluorescein-5-isothiocyanate; Genes, Reporter; Genetic Therapy; Humans; Immunity; Immunohistochemistry; In Situ Nick-End Labeling; Killer Cells, Natural; Liver Neoplasms; Luciferases; Mice, Nude; Neoplasms; Oligodeoxyribonucleotides; Real-Time Polymerase Chain Reaction; STAT3 Transcription Factor; Transfection | 2015 |
Size- and shape-dependent peroxidase-like catalytic activity of MnFe2O4 Nanoparticles and their applications in highly efficient colorimetric detection of target cancer cells.
Topics: Animals; Benzidines; Catalysis; Cell Survival; Colorimetry; Ferric Compounds; Fluorescein-5-isothiocyanate; Folic Acid; Folic Acid Transporters; HeLa Cells; Humans; Hydrogen Peroxide; Manganese Compounds; Metal Nanoparticles; Mice; Neoplasms; NIH 3T3 Cells; Peroxidase | 2015 |
Supramolecular Fluorescent Nanoparticles Constructed via Multiple Non-Covalent Interactions for the Detection of Hydrogen Peroxide in Cancer Cells.
Topics: beta-Cyclodextrins; Fluorescein-5-isothiocyanate; Fluorescence; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; Humans; Hydrogen Peroxide; Molecular Imaging; Nanoparticles; Neoplasms; Spectrometry, Fluorescence; Thiocyanates; Water | 2015 |
Integrin αvβ3 targeting activity study of different retro-inverso sequences of RGD and their potentiality in the designing of tumor targeting peptides.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Design; Fluorescein-5-isothiocyanate; HeLa Cells; Humans; Integrin alphaVbeta3; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Neoplasms; Oligopeptides; Xenograft Model Antitumor Assays | 2015 |
pH-sensitive nanocarrier based on gold/silver core-shell nanoparticles decorated multi-walled carbon manotubes for tracing drug release in living cells.
Topics: Biosensing Techniques; Cell Line, Tumor; Doxorubicin; Drug Liberation; Fluorescein-5-isothiocyanate; Gold; Humans; Hydrogen-Ion Concentration; Nanoshells; Nanotubes, Carbon; Neoplasms; Silver; Spectrum Analysis, Raman | 2016 |
Multi-small molecule conjugations as new targeted delivery carriers for tumor therapy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Arginine; Cell Line, Tumor; Cell Survival; Chemical Phenomena; Drug Carriers; Female; Fluorescein-5-isothiocyanate; Folic Acid; Glutamic Acid; HEK293 Cells; Humans; Lethal Dose 50; Male; Mice; Mice, Nude; Molecular Weight; Neoplasms; Paclitaxel; Prodrugs; Solubility; Toxicity Tests, Acute; Xenograft Model Antitumor Assays | 2015 |
Targeting and Imaging of Cancer Cells via Monosaccharide-Imprinted Fluorescent Nanoparticles.
Topics: Fluorescein-5-isothiocyanate; Hep G2 Cells; Humans; MCF-7 Cells; Molecular Imprinting; Monosaccharides; Nanoparticles; Neoplasms; Silicon Dioxide | 2016 |
Synthesis, characterization, and evaluation of mPEG-SN38 and mPEG-PLA-SN38 micelles for cancer therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Camptothecin; Cell Line, Tumor; Drug Liberation; Endocytosis; Fluorescein-5-isothiocyanate; Humans; Irinotecan; Mice, Inbred BALB C; Mice, Nude; Micelles; Neoplasms; Polyesters; Polyethylene Glycols; Tissue Distribution; Treatment Outcome | 2016 |
Regulating CAR T Cells: A Remote Control Approach.
Topics: Animals; Cell Line, Tumor; Fluorescein-5-isothiocyanate; Humans; Mice; Neoplasms; Receptors, Antigen, T-Cell; T-Lymphocytes | 2016 |
Conjugates of HA2 with octaarginine-grafted HPMA copolymer offer effective siRNA delivery and gene silencing in cancer cells.
Topics: A549 Cells; Acrylamides; Cell Line, Tumor; Cytoplasm; Endosomes; Female; Fluorescein-5-isothiocyanate; Gene Expression Regulation, Neoplastic; Gene Silencing; Gene Transfer Techniques; Humans; Microscopy, Confocal; Neoplasms; Oligopeptides; Ovarian Neoplasms; Peptides; Polymers; Real-Time Polymerase Chain Reaction; RNA; RNA Interference; RNA, Small Interfering; Surface Properties | 2016 |
PBCA-based polymeric microbubbles for molecular imaging and drug delivery.
Topics: Animals; Antibodies; Biotin; Brain; Carotid Arteries; Cell Line, Tumor; Dextrans; Drug Delivery Systems; E-Selectin; Enbucrilate; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Male; Mice, Nude; Microbubbles; Molecular Imaging; Neoplasms; Neovascularization, Pathologic; Rhodamines; Streptavidin; Ultrasonic Waves; Ultrasonography; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor Receptor-2 | 2017 |
Super pH-sensitive multifunctional polymeric micelle for tumor pH(e) specific TAT exposure and multidrug resistance.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Endosomes; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Genes, tat; Humans; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Mice; Mice, Nude; Micelles; Neoplasms; Polymers; Tumor Burden; Xenograft Model Antitumor Assays | 2008 |
Targeting cancer cells with biotin-dendrimer conjugates.
Topics: Antineoplastic Agents; Biocompatible Materials; Biotin; Dendrimers; Drug Delivery Systems; Fluorescein-5-isothiocyanate; HeLa Cells; Humans; Neoplasms; Polyamines | 2009 |
Characterization of tumor cell dissemination patterns in preclinical models of cancer metastasis using flow cytometry and laser scanning cytometry.
Topics: Animals; Antibodies; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; HLA Antigens; Humans; Laser Scanning Cytometry; Leukocyte Common Antigens; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasms; Neoplasms, Experimental; Time Factors | 2009 |
Porous-wall hollow glass microspheres as novel potential nanocarriers for biomedical applications.
Topics: Animals; Dextrans; Drug Carriers; Drug Delivery Systems; Fluorescein-5-isothiocyanate; Fluorescence; Glass; Humans; Injections; Mice; Mice, Nude; Microspheres; Molecular Weight; Nanostructures; Neoplasms; Nucleic Acids; Particle Size; Porosity; Proteins; Xenograft Model Antitumor Assays | 2010 |
Ultrasmall near-infrared non-cadmium quantum dots for in vivo tumor imaging.
Topics: 3-Mercaptopropionic Acid; Animals; Cadmium; Diagnostic Imaging; Female; Fluorescein-5-isothiocyanate; Humans; Lectins; Mice; Mice, Nude; Nanoparticles; Neoplasms; Organ Specificity; Quantum Dots; Spectroscopy, Near-Infrared | 2010 |
Dendrimer-based tumor cell targeting of fibroblast growth factor-1.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Nucleus; Dendrimers; Drug Delivery Systems; Fibroblast Growth Factor 1; Flow Cytometry; Fluorescein-5-isothiocyanate; Humans; Neoplasms; Polyamines; Receptors, Fibroblast Growth Factor; Recombinant Proteins | 2010 |
Gadolinium-conjugated dendrimer nanoclusters as a tumor-targeted T1 magnetic resonance imaging contrast agent.
Topics: Animals; Contrast Media; Cross-Linking Reagents; Dendrimers; Electron Spin Resonance Spectroscopy; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Folic Acid; Gadolinium; Gadolinium DTPA; Humans; KB Cells; Magnetic Resonance Imaging; Mice; Microscopy, Electron, Transmission; Nanoparticles; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental | 2010 |
The combretastatin derivative (Cderiv), a vascular disrupting agent, enables polymeric nanomicelles to accumulate in microtumors.
Topics: Animals; Antineoplastic Agents; Bibenzyls; Blood Vessels; Fluorescein; Fluorescein-5-isothiocyanate; Hemodynamics; Male; Neoplasms; Oxides; Polymers; Rats; Serum Albumin | 2010 |
The anti-cancer peptide, PNC-27, induces tumor cell lysis as the intact peptide.
Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Cell Membrane; Coloring Agents; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Green Fluorescent Proteins; Humans; L-Lactate Dehydrogenase; Microscopy, Confocal; Necrosis; Neoplasms; Rhodamines; Tetrazolium Salts; Thiazoles; Tumor Suppressor Protein p53 | 2010 |
Noncompetitive immunoassay for carcinoembryonic antigen in human serum by microchip electrophoresis for cancer diagnosis.
Topics: Antibodies, Monoclonal; Blood Chemical Analysis; Buffers; Carcinoembryonic Antigen; Electricity; Electrophoresis; Fluorescein-5-isothiocyanate; Humans; Hydrogen-Ion Concentration; Immunoassay; Injections; Microchip Analytical Procedures; Neoplasms; Sodium Dodecyl Sulfate; Spectrometry, Fluorescence; Time Factors | 2010 |
Core-shell nanosized assemblies mediated by the alpha-beta cyclodextrin dimer with a tumor-triggered targeting property.
Topics: alpha-Cyclodextrins; beta-Cyclodextrins; Cell Survival; Dimerization; Doxorubicin; Drug Carriers; Fluorescein-5-isothiocyanate; Fluorescent Dyes; HeLa Cells; Humans; Hydrophobic and Hydrophilic Interactions; Micelles; Nanoshells; Neoplasms; Oligopeptides; Polyethylene Glycols; Rhodamines | 2010 |
Charge-reversal polyamidoamine dendrimer for cascade nuclear drug delivery.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Cell Nucleus; Dendrimers; Drug Carriers; Female; Fluorescein-5-isothiocyanate; Humans; Hydrogen-Ion Concentration; Kinetics; Magnetic Resonance Spectroscopy; Neoplasms; Ovarian Neoplasms; Polyamines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2010 |
Dynamic contrast enhanced optical imaging of capillary leakage.
Topics: Animals; Capillaries; Capillary Permeability; Contrast Media; Fiber Optic Technology; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Mice; Microcirculation; Microscopy, Confocal; Microscopy, Fluorescence; Molecular Weight; Muscles; Neoplasms; Phantoms, Imaging; Serum Albumin; Splanchnic Circulation | 2011 |
2D luminescence imaging of pH in vivo.
Topics: Biosensing Techniques; Cell Line; Fluorescein-5-isothiocyanate; Humans; Hydrogen-Ion Concentration; Keratinocytes; Luminescence; Neoplasms; Organometallic Compounds; Phenanthrolines; Wound Healing | 2011 |
Encapsulation of 2-methoxyestradiol within multifunctional poly(amidoamine) dendrimers for targeted cancer therapy.
Topics: 2-Methoxyestradiol; Cell Line, Tumor; Cell Survival; Dendrimers; Estradiol; Fluorescein-5-isothiocyanate; Folic Acid; Humans; Kinetics; Magnetic Resonance Spectroscopy; Microscopy, Confocal; Neoplasms; Organ Specificity; Spectrophotometry, Ultraviolet; Static Electricity | 2011 |
Highly efficient intracellular drug delivery with a negatively charged hyperbranched polysulfonamine.
Topics: Amines; Animals; Anions; Biological Transport; Cell Proliferation; Cell Survival; Delayed-Action Preparations; Doxorubicin; Drug Carriers; Endocytosis; Fluorescein-5-isothiocyanate; HEK293 Cells; Humans; Hydrogen-Ion Concentration; Mice; Neoplasms; NIH 3T3 Cells; Polymers; Static Electricity; Sulfones | 2011 |
PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.
Topics: Animals; Antineoplastic Agents; Caveolin 1; Cell Line, Tumor; Cisplatin; Clathrin; Drug Carriers; Drug Delivery Systems; Fluorescein-5-isothiocyanate; Folic Acid; Folic Acid Transporters; HEK293 Cells; HeLa Cells; Humans; Mice; Microscopy, Electron, Transmission; Models, Biological; Nanoparticles; Neoplasms; Particle Size; Polyethylene Glycols; Silicon Dioxide; Surface-Active Agents | 2011 |
Distinct transduction modes of arginine-rich cell-penetrating peptides for cargo delivery into tumor cells.
Topics: Animals; Arginine; Avidin; Biological Transport; Cell Line, Tumor; Cell Membrane; Cell-Penetrating Peptides; Drug Delivery Systems; Endocytosis; Fluorescein-5-isothiocyanate; Heparan Sulfate Proteoglycans; Humans; Mice; Molecular Weight; Neoplasms; Rats; Temperature; Time Factors | 2011 |
Microchip fluorescence-enhanced immunoaasay for simultaneous quantification of multiple tumor markers.
Topics: Antibodies, Monoclonal; Antigen-Antibody Complex; Biomarkers, Tumor; CA-125 Antigen; Electrophoresis, Microchip; Fluorescein-5-isothiocyanate; Humans; Immunoassay; Mucin-1; Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Sodium Dodecyl Sulfate; Spectrometry, Fluorescence | 2011 |
In vitro antioxidant and antiproliferative potential of medicinal plants used in traditional Indian medicine to treat cancer.
Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Biphenyl Compounds; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flow Cytometry; Fluorescein-5-isothiocyanate; Humans; India; Magnoliopsida; MCF-7 Cells; Medicine, East Asian Traditional; Neoplasms; Nitric Oxide; Picrates; Plant Extracts; Tetrazolium Salts; Thiazoles | 2012 |
Enhanced delivery of T cells to tumor after chemotherapy using membrane-anchored, apoptosis-targeted peptide.
Topics: Animals; Apoptosis; Biocompatible Materials; Cell Line, Tumor; Cell Membrane; Fluorescein-5-isothiocyanate; Humans; Immunotherapy, Adoptive; Mice; Neoplasms; Oligopeptides; Polyethylene Glycols; T-Lymphocytes; Xenograft Model Antitumor Assays | 2012 |
Effect of PSK on the maturation of dendritic cells derived from human peripheral blood monocytes.
Topics: Animals; Antigens, CD; Biological Transport; Cell Differentiation; Cells, Cultured; Cytotoxicity, Immunologic; Dendritic Cells; Dextrans; Fluorescein-5-isothiocyanate; HLA-DR Antigens; Humans; Interleukin-12; Lymphocyte Culture Test, Mixed; Lymphocytes; Mice; Monocytes; Neoplasms; Polysaccharides; RNA, Messenger; Tumor Necrosis Factor-alpha | 2004 |
Measurement of macromolecular diffusion coefficients in human tumors.
Topics: Animals; Biological Transport; Cell Line, Tumor; Collagen; Diffusion; Extracellular Matrix; Fluorescein-5-isothiocyanate; Fluorescence Recovery After Photobleaching; Fourier Analysis; Humans; Immunoglobulin M; Macromolecular Substances; Mice; Mice, SCID; Microscopy, Fluorescence; Microscopy, Fluorescence, Multiphoton; Neoplasm Transplantation; Neoplasms; Serum Albumin, Bovine; Temperature; Transplantation, Heterologous | 2004 |
Improved immunohistochemical method for detecting hypoxia gradients in mouse tissues and tumors.
Topics: Animals; Antibodies, Monoclonal; Cell Hypoxia; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Immunohistochemistry; Mice; Neoplasms; Nitroimidazoles; Organ Specificity | 2004 |
Differential up-regulation of cytosolic and membrane-bound heat shock protein 70 in tumor cells by anti-inflammatory drugs.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Aspirin; Celecoxib; Cell Line, Tumor; Cell Membrane; Cell Survival; Cytoplasm; Cytosol; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Flow Cytometry; Fluorescein-5-isothiocyanate; Granzymes; HSP70 Heat-Shock Proteins; Humans; Immunoblotting; Immunotherapy; Insulin; Kinetics; Lactones; Models, Chemical; Neoplasms; Pioglitazone; Pyrazoles; Serine Endopeptidases; Sulfonamides; Sulfones; Thiazolidinediones; Up-Regulation | 2004 |
Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts.
Topics: Animals; Basement Membrane; Endothelium, Vascular; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Immunohistochemistry; Lectins; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Confocal; Microscopy, Electron; Microscopy, Electron, Scanning; Neoplasms; Neovascularization, Pathologic; Signal Transduction; Vascular Endothelial Growth Factor A | 2004 |
Radiation-guided drug delivery to tumor blood vessels results in improved tumor growth delay.
Topics: Angiogenesis Inhibitors; Animals; Cisplatin; Combined Modality Therapy; Disease Models, Animal; Drug Delivery Systems; Drug Screening Assays, Antitumor; Female; Fluorescein-5-isothiocyanate; Indium Radioisotopes; Liposomes; Mice; Mice, Inbred C57BL; Neoplasms; Neoplasms, Experimental; Neutron Capture Therapy; Radiation-Sensitizing Agents; Radiometry; Skin; Tumor Cells, Cultured; Wheat Germ Agglutinins | 2004 |
The NH2 terminus of influenza virus hemagglutinin-2 subunit peptides enhances the antitumor potency of polyarginine-mediated p53 protein transduction.
Topics: Animals; Antineoplastic Agents; Apoptosis; Astrocytes; Blotting, Western; Cell Cycle Proteins; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cell Survival; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p21; Drug Synergism; Fluorescein-5-isothiocyanate; Genes, Reporter; Hemagglutinins, Viral; Humans; Hydrogen-Ion Concentration; In Situ Nick-End Labeling; Mutagenesis, Site-Directed; Neoplasms; Orthomyxoviridae; Peptides; Protein Binding; Protein Structure, Tertiary; Rats; Rats, Wistar; Recombinant Fusion Proteins; Time Factors; Transcriptional Activation; Tumor Suppressor Protein p53 | 2005 |
A new prostate carcinoma binding peptide (DUP-1) for tumor imaging and therapy.
Topics: Animals; Antigens, Neoplasm; Cell Line, Tumor; Dose-Response Relationship, Drug; Fluorescein-5-isothiocyanate; Humans; Kinetics; Male; Mice; Mice, Nude; Microscopy, Confocal; Microscopy, Fluorescence; Neoplasm Transplantation; Neoplasms; Peptides; Prostatic Neoplasms; Protein Binding; Rats; Sensitivity and Specificity; Time Factors; Tissue Distribution | 2005 |
Targeting cancer cells with DNA-assembled dendrimers: a mix and match strategy for cancer.
Topics: Animals; Antineoplastic Agents; Carrier Proteins; Dendrimers; DNA, Complementary; Drug Carriers; Drug Delivery Systems; Fluorescein-5-isothiocyanate; Folate Receptors, GPI-Anchored; Folic Acid; Gene Expression Regulation, Neoplastic; Humans; Nanotechnology; Neoplasms; Oligonucleotides; Protein Binding; Receptors, Cell Surface | 2005 |
Non-antigen-specific CD8(+) T suppressor lymphocytes in diseases characterized by chronic immune responses and inflammation.
Topics: Antibodies, Monoclonal; CD8 Antigens; CD8-Positive T-Lymphocytes; Cell Culture Techniques; Cell Proliferation; Cells, Cultured; Chronic Disease; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique; Fluorescent Dyes; Graves Disease; Hepatitis C, Chronic; HIV; Humans; Inflammation; Lymphatic Metastasis; Neoplasms; Statistics, Nonparametric; T-Lymphocytes, Regulatory; Thyroiditis, Autoimmune | 2005 |
Folate conjugated fluorescent silica nanoparticles for labeling neoplastic cells.
Topics: Biomarkers, Tumor; Carrier Proteins; Cell Line; Coated Materials, Biocompatible; Fibroblasts; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Materials Testing; Microscopy, Fluorescence; Nanotubes; Neoplasms; Particle Size; Receptors, Cell Surface; Silicon Dioxide; Staining and Labeling | 2005 |
Microarray analysis identifies apoptosis regulatory gene expression in HCT116 cells infected with thermostable direct hemolysin-deletion mutant of Vibrio parahaemolyticus.
Topics: Annexin A5; Apoptosis; Bacterial Toxins; Blotting, Northern; Blotting, Western; Cell Line, Tumor; DNA Damage; DNA Fragmentation; DNA, Complementary; Electrophoresis, Agar Gel; Fluorescein-5-isothiocyanate; Gene Deletion; Gene Expression Regulation, Neoplastic; Hemolysin Proteins; Humans; Immunoblotting; Mutation; Neoplasms; Oligonucleotide Array Sequence Analysis; Vibrio parahaemolyticus | 2005 |
Heat labile enterotoxin of E. coli: a potential adjuvant for transcutaneous cancer immunotherapy.
Topics: Adjuvants, Immunologic; Amino Acid Sequence; Animals; Antibody Formation; Bacterial Toxins; Cancer Vaccines; CD8-Positive T-Lymphocytes; Dendritic Cells; Drug Carriers; Enterotoxins; Escherichia coli Proteins; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Immunotherapy; Interleukin-12; Melanoma; Mice; Molecular Sequence Data; Monocytes; Neoplasms; Peroxidase; Skin | 2006 |
NPI-2358 is a tubulin-depolymerizing agent: in-vitro evidence for activity as a tumor vascular-disrupting agent.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Cell Membrane Permeability; Cell Survival; Colchicine; Dextrans; Diketopiperazines; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Endothelial Cells; Endothelium, Vascular; Fluorescein-5-isothiocyanate; HL-60 Cells; HT29 Cells; Humans; Imidazoles; Inhibitory Concentration 50; Jurkat Cells; Microtubules; Neoplasms; Piperazines; Stilbenes; Time Factors; Tubulin; Vincristine | 2006 |
Photochemical internalization of therapeutic macromolecular agents: a novel strategy to kill multidrug-resistant cancer cells.
Topics: Adenoviridae; Cell Line, Tumor; Dextrans; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorescein-5-isothiocyanate; Humans; Neoplasms; Photochemotherapy; Photosensitizing Agents; Porphyrins | 2006 |
Normalized transillumination of fluorescent proteins in small animals.
Topics: Animals; Diagnostic Imaging; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Lighting; Mice; Mice, Nude; Models, Biological; Models, Theoretical; Neoplasms; Recombinant Fusion Proteins; Tomography, X-Ray Computed; Transillumination | 2006 |
Identification of a novel peptide ligand of human vascular endothelia growth factor receptor 3 for targeted tumour diagnosis and therapy.
Topics: Amino Acid Sequence; Binding Sites; Cell Line, Tumor; Databases, Protein; Endothelial Cells; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique; Humans; Ligands; Molecular Sequence Data; Neoplasms; Oligopeptides; Peptide Library; Peptides; Vascular Endothelial Growth Factor Receptor-3 | 2007 |
Vitamins K2, K3 and K5 exert antitumor effects on established colorectal cancer in mice by inducing apoptotic death of tumor cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Colorectal Neoplasms; Dose-Response Relationship, Drug; Fluorescein-5-isothiocyanate; Humans; Mice; Neoplasm Transplantation; Neoplasms; Propidium; Vitamin K 2; Vitamin K 3 | 2007 |
Photokilling cancer cells using highly cell-specific antibody-TiO(2) bioconjugates and electroporation.
Topics: Antibodies, Monoclonal; Antibody Specificity; Carcinoembryonic Antigen; Cell Death; Cell Line; Cell Line, Tumor; Electrochemotherapy; Fluorescein-5-isothiocyanate; Humans; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Nanoparticles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Spectrometry, Fluorescence; Titanium; Ultraviolet Rays | 2007 |
Improved cytosolic translocation and tumor-killing activity of Tat-shepherdin conjugates mediated by co-treatment with Tat-fused endosome-disruptive HA2 peptide.
Topics: Cell Line, Tumor; Cell Survival; Cytosol; Endosomes; Fluorescein-5-isothiocyanate; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; Peptide Fragments; Peptides; Protein Transport; tat Gene Products, Human Immunodeficiency Virus | 2007 |
Near-infrared fluorescent labeled peptosome for application to cancer imaging.
Topics: Animals; Circular Dichroism; Drug Carriers; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Infrared Rays; Male; Mice; Micelles; Nanostructures; Neoplasms; Peptides; Permeability; Polyglutamic Acid; Rats; Sarcosine | 2008 |
Enhancing ultrasound-mediated cell membrane permeabilisation (sonoporation) using a high frequency pulse regime and implications for ultrasound-aided cancer chemotherapy.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Cell Membrane Permeability; Combined Modality Therapy; Dextrans; Fluorescein-5-isothiocyanate; Fluorescent Dyes; HeLa Cells; Humans; Neoplasms; Ultrasonics | 2008 |
Transferrin receptor expression during exponential and plateau phase growth of human tumour cells in culture.
Topics: Apoproteins; Cell Cycle; Cell Division; Cells, Cultured; Fluorescein-5-isothiocyanate; Fluoresceins; Humans; Neoplasms; Receptors, Cell Surface; Receptors, Transferrin; Thiocyanates; Transferrin | 1984 |
Flow cytometric measurements of phagocytosis. I. A methodical and comparative study.
Topics: Erythrocytes; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent Dyes; Humans; Latex; Leukocytes; Neoplasms; Phagocytosis; Thiocyanates | 1984 |
Fluorescein-concanavalin A conjugates distinguish between normal and malignant human cells: a preliminary report.
Topics: Breast Neoplasms; Concanavalin A; Female; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent Antibody Technique; Humans; Liver Neoplasms; Lung Neoplasms; Neoplasms; Pancreatic Neoplasms; Skin; Skin Neoplasms; Thiocyanates | 1981 |
Molecular cytogenetic analysis of formalin-fixed, paraffin-embedded solid tumors by comparative genomic hybridization after universal DNA-amplification.
Topics: Base Sequence; Chromosome Aberrations; Chromosome Mapping; DNA Primers; DNA, Neoplasm; Fluorescein-5-isothiocyanate; Formaldehyde; Genome, Human; Histological Techniques; Humans; Karyotyping; Molecular Sequence Data; Neoplasms; Nucleic Acid Hybridization; Paraffin; Polymerase Chain Reaction | 1993 |
One-tube triple staining method for flow cytometric analysis of DNA ploidy and phenotypic heterogeneity of human solid tumors using single laser excitation.
Topics: Biomarkers; Cell Survival; Coloring Agents; DNA, Neoplasm; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Genetic Heterogeneity; Humans; Intermediate Filaments; Lasers; Neoplasms; Ovarian Neoplasms; Phenotype; Phycoerythrin; Ploidies; Proliferating Cell Nuclear Antigen; Propidium; Staining and Labeling | 1996 |
A highly sensitive model for quantification of in vivo tumor angiogenesis induced by alginate-encapsulated tumor cells.
Topics: Alginates; Animals; Antibiotics, Antineoplastic; Carcinoma, Lewis Lung; Carcinoma, Renal Cell; Cyclohexanes; Dextrans; Drug Carriers; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Glucuronic Acid; Hemostatics; Hexuronic Acids; Kidney Neoplasms; Mice; Mice, Inbred C57BL; Mice, Nude; Microspheres; Molecular Weight; Neoplasms; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Sesquiterpenes; Tumor Cells, Cultured | 1997 |
Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors.
Topics: Chromosome Mapping; DNA Probes; DNA, Neoplasm; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Gene Amplification; Gene Deletion; Humans; In Situ Hybridization, Fluorescence; Male; Mutation; Neoplasms; Nucleic Acid Hybridization; Oncogenes; Polymorphism, Restriction Fragment Length; Rhodamines; Tumor Cells, Cultured | 1992 |
Host cell range of adult T-cell leukemia virus. I. Viral infectivity and binding to various cells as detected by flow cytometry.
Topics: Animals; Callitrichinae; Cell Line; Deltaretrovirus; Erythrocytes; Fibroblasts; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent Antibody Technique; Humans; Leukemia; Lymphocytes; Lymphoma; Mice; Mice, Inbred BALB C; Neoplasms; Rabbits; Receptors, Virus; Spleen; Thiocyanates; Virus Cultivation | 1985 |